实用肝脏病杂志 ›› 2023, Vol. 26 ›› Issue (5): 630-633.doi: 10.3969/j.issn.1672-5069.2023.05.007

• 病毒性肝炎 • 上一篇    下一篇

慢性乙型肝炎患者肝脏硬度检测和S指数变化及评估肝纤维化程度应用价值探讨*

郝岸华, 杜忠彩, 周林, 马磊   

  1. 266000 山东省青岛市城阳区人民医院感染性疾病科(郝岸华,周林,马磊);青岛大学附属医院感染性疾病科(杜忠彩)
  • 收稿日期:2022-11-14 出版日期:2023-09-10 发布日期:2023-09-13
  • 通讯作者: 马磊,E-mail:maleipretty@126.com
  • 作者简介:郝岸华,女,40岁,医学硕士,主治医师。E-mail:qingyixiaohao123@126.com
  • 基金资助:
    *青岛市卫健委科研课题(编号:2017-YJZD098)

Changes of liver stiffness measurement and S index in patients with chronic hepatitis B and their performance in evaluating liver fibrosis

Hao Anhua, Du Zhongcai, Zhou Lin, et al   

  1. Department of Infectious Diseases, People's Hospital, Chengyang District 266000, Qingdao, Shandong Province, China
  • Received:2022-11-14 Online:2023-09-10 Published:2023-09-13

摘要: 目的 探讨慢性乙型肝炎(CHB)患者肝脏硬度检测(LSM)和S指数变化及在评估肝纤维化程度方面的应用价值。 方法 2020年6月~2022年6月我院收治的CHB患者95例,均接受肝穿刺活检,采用Scheuer System评分系统评估肝组织炎症和纤维化程度。使用超声弹性成像仪行肝脏硬度检测(LSM),使用全自动生化分析仪检测血生化指标,计算S指数。应用SPSS 25.0统计学软件绘制受试者工作特征曲线(ROC),计算曲线下面积(AUC),判断LSM和S指数诊断肝纤维化程度的效能。 结果 在95例CHB患者中,经肝组织学检查发现非显著性炎症患者66例,显著性炎症者29例及肝纤维化分期S0~S1者62例,S2者19例和S3~S4者14例;显著性炎症CHB患者LSM和S指数分别为(9.6±1.2)kPa和(0.9±0.2),显著高于非显著性炎症CHB患者【分别为(6.7±0.8) kPa和(0.5±0.1),P<0.05)】;肝纤维化S3~S4的CHB患者LSM和S指数分别为(11.2±2.3) kPa和(1.1±0.2),显著高于肝纤维化S2的CHB患者【分别为(8.4±1.5) kPa和(0.9±0.2),P<0.05】或肝纤维化S0~S1的CHB患者【分别为(5.7±1.1)kPa和(0.4±0.1),P<0.05】;LSM和S指数诊断显著性肝纤维化的AUC分别为0.891(95%CI:0.811~0.946,P<0.001)和0.889(95%CI:0.808~0.944,P<0.001),其敏感度分别为0.879和0.727,特异度分别为0.807和0.887;LSM和S指数诊断进展期肝纤维化的AUC分别为0.872(95%CI:0.787~0.932,P<0.001)和0.807(95%CI:0.713~0.881,P<0.001),其敏感度均为0.786,特异度分别为0.938和0.765。 结论 CHB患者LSM和S指数与肝纤维化程度密切相关,监测LSM和S指数变化有助于评估患者肝纤维化程度。

关键词: 慢性乙型肝炎, 肝脏硬度检测, S指数, 肝纤维化, 诊断

Abstract: Objective The aim of this study was to explore the changes of liver stiffness measurement (LSM) and S index in patients with chronic hepatitis B (CHB) and their diagnostic performance in evaluating liver fibrosis (LF). Methods A total of 95 patients with CHB were enrolled in our hospital between June 2020 and June 2022, and all patients underwent liver biopsy. The histological activity index and fibrosis staging were evaluated by Scheuer scoring system. The ultrasonic elastography was used to detect LSM. Serum glutamyl transpeptidease (GGT), albumin (ALB) and blood platelet count (PLT) were detected and S index was calculated. The receiver operating characteristic (ROC) curves were drawn by SPSS 25.0 statistical software, and the area under the curve (AUC) was calculated to determine the diagnostic efficacy of LSM and S index for the severity of LF. Results The liver histological examination showed that out of the 95 patients with CHB, there were 66 cases with non-significant intrahepatic inflammation and 29 cases with significant liver inflammation,and there were 62 cases with liver fibrosis stage S0-S1, 19 cases with stage S2 and 14 cases with stage S3-S4; the LSM and S index in CHB patients with significant intrahepatic inflammation were (9.6±1.2)kPa and (0.9±0.2), significantly higher than [(6.7±0.8) kPa and (0.5±0.1), respectively, P<0.05)] in patients without significant liver inflammation; the LSM and S index in patient with S3-S4 were (11.2±2.3) kPa and (1.1±0.2), significantly higher than [(8.4±1.5) kPa and (0.9±0.2), P<0.05] in patients with S2 or [(5.7±1.1)kPa and (0.4±0.1), P<0.05] in patients with S0-S1; the AUCs were 0.891(95%CI:0.811-0.946, P<0.001) and 0.889(95%CI:0.808-0.944, P<0.001) when the LSM and S index were applied to predict significant LF, with the sensitivities (Se) of 0.879 and 0.727, and the specificities (Sp) of 0.807 and 0.887; the AUCs were 0.872(95%CI:0.787-0.932, P<0.001) and 0.807(95%CI:0.713-0.881, P<0.001) when the LSM and S index were applied to predict the advanced LF, with the Se of 0.786 and 0.786, and the Sp of 0.938 and 0.765. Conclusion The LSM and S index are closely correlated to the severity of LF in patients with CHB, and monitoring their changes might be beneficial to evaluate the severity of LF.

Key words: Hepatitis B, Liver stiffness measurement, S index, Liver fibrosis, Diagnosis